Allergic diseases in the pediatric population are a significant burden to
healthcare systems, families, and children themselves. They decrease patients’
quality of life. Some allergic conditions are life-threatening. Therefore, it is vital
to investigate new pathways that could facilitate their treatment and prevention.
This review gathers information from recent studies regarding probiotics as an
additive therapy in allergic bronchial asthma, atopic dermatitis, allergic rhinitis,
and food allergy. In light of the increasing prevalence of atopic diseases among
children worldwide the “Hygiene hypothesis” gained interest among scientists. It
associates the rising incidence of allergies with limited exposure to the natural
environment and infectious diseases in early childhood. This absence of immune
stimulation presumably causes immunity dysregulation and
hyperresponsiveness, resulting in atopy. Probiotics supplementation, aiming to
enrich the gut microbiota, has become a field of research. There is hope that a
more diverse and abundant microbiome will result in immunity maturation and
immunotolerance. Outcomes of conducted trials in the subject vary from
apparent preventive or alleviating symptoms effect to no significant difference
noted. The authors point out that there should be more research focused on
single bacterial strains in a specific disease, precise dosage, and administration
period. Overall, taking into account the latest reports, there are more and more
studies that show the beneficial effects of probiotics on allergic diseases.
However, there is not enough evidence to make recommendations regarding
their routine use.
Keywords: Allergy; probiotics; hygiene; microbiota
